Methods 120 patients with ACS and 94 healthy people were adopted in the study. Plasma CRP were measured and the risk for major adverse cardiac events(MACE) at 30 days and 3 months were analyzed.

• 方法测定120例ACS患者和94例健康对照组的血浆CRP水平,随访ACS患者住院期间、30天以及3个月死亡事件以及MACE发生率。